GUIDED BREAST BIOPSY ULTRASOUND
Also Known As
SENIOR
FLAT 10% OFF FOR SENIOR CITIZENS
FAMILY
ADD A FAMILY MEMBER FOR 20% DISCOUNT

Certified Labs
NABH Accredited
Reports in
Not specified
Measures
No description available
Identifies
No identification information available
About The Test
- What it is: A quick, outpatient test using ultrasound to steer a needle to a breast lesion for tissue sampling.
- Why Cadabams Diagnostics:
• Over 30 years of breast-imaging expertise
• On-site pathologists for 24–48-hour turnaround
• Dedicated women’s-health suites designed for privacy and calm
• Patient navigators who explain each step in everyday language
What Is Guided Breast Biopsy Ultrasound?
Definition
A guided breast biopsy ultrasound combines high-frequency sound waves with a hollow needle to obtain tiny tissue samples from a breast lump or abnormality. The radiologist watches the needle in real time on an ultrasound monitor, ensuring pinpoint accuracy without radiation.
How It Differs From Other Techniques
Technique | Guidance | Best For | Radiation? |
---|---|---|---|
Ultrasound-guided | Sound waves | Cysts, solid masses | No |
Stereotactic | Mammogram X-ray | Micro-calcifications | Yes |
MRI-guided | Magnetic resonance | Dense breasts, implants | No |
Types of Guided Breast Biopsy Ultrasound
- Fine-Needle Aspiration (FNA) – 23–25 gauge needle; quick fluid or cell sampling
- Core Needle Biopsy (CNB) – 14–16 gauge spring-loaded needle; retrieves 3–6 cylindrical cores for detailed pathology
- Vacuum-Assisted Biopsy (VAB) – Larger 9–11 gauge probe; collects multiple contiguous samples in one pass, ideal for small lesions
List of Parameters
Radiologists evaluate:
- Lesion size and shape
- Margins (smooth vs. irregular)
- Vascularity on color Doppler
- Echogenicity (hypoechoic, isoechoic, hyperechoic)
- Posterior acoustic features (shadowing or enhancement)
Why This Test
- Confirm or rule out breast cancer
- Determine hormone-receptor status (ER, PR, HER2) to tailor treatment
- Guide surgical planning (lumpectomy vs. mastectomy)
- Assess response to neoadjuvant therapy
When to Take Test
Indications
- Suspicious finding on screening mammogram or breast ultrasound
- New palpable lump felt during self-exam
- Follow-up of abnormal MRI findings
- Persistent breast pain localized to one spot
Risk-Factor Considerations - Ages 30–65 with dense breast tissue
- Family history of breast cancer
- Prior inconclusive core biopsy
- Pregnancy-safe alternative to stereotactic biopsy
Benefits
Benefits
- Real-time targeting—no guesswork, minimal healthy tissue removal
- Zero radiation—safe during pregnancy and for repeat procedures
- Outpatient convenience—arrive, biopsy, and go home within 2 hours
- Same-day recovery—resume normal life quickly with simple after-care instructions
Illnesses Diagnosed
Condition | Typical Ultrasound Appearance |
---|---|
Invasive ductal carcinoma | Irregular, hypoechoic mass with spiculated margins |
DCIS | Ductal wall thickening, microcalcifications may be absent |
Fibroadenoma | Oval, well-circumscribed, “pushing” margins |
Intraductal papilloma | Intraductal mass with vascular stalk |
Mastitis/abscess | Hypoechoic collection with surrounding hyperemia |
Preparing for test
- Pause blood thinners (aspirin, clopidogrel, warfarin) only if your doctor okays it
- No fasting required—eat a light meal to avoid dizziness
- Wear a front-opening top and avoid deodorant or talc on the day
- Bring prior imaging reports on a CD or QR code for comparison
Prerequisites
- Recent mammogram or breast ultrasound images (within 6 months)
- Coagulation profile (PT/INR, platelet count) if you take anticoagulants
- Completed consent form and allergy list
Best Time to Take the Test
- Schedule between day 7–10 of the menstrual cycle when breasts are least tender
- Avoid scheduling during an active breast infection or within 4 weeks of giving birth
Eligibility
- All women with palpable or non-palpable breast lesions visible on ultrasound
- Pregnant women—procedure is radiation-free and safe in any trimester
- Men with suspicious breast lumps (rare but possible)
Step-by-Step Procedure
- Positioning – Lie on your back or turned slightly to the side; arm above head
- Skin prep – Antiseptic cleansing and sterile drapes
- Local anesthesia – 1–2 cc lidocaine; you stay awake and comfortable
- Needle insertion – Real-time ultrasound guides the needle; 3–6 samples taken
- Post-procedure – Adhesive dressing and light compression; 15-minute observation
Caution Before the Test
- Disclose metal allergies to nickel if vacuum-assisted device is planned
- Inform about pacemaker or implantable devices (rare contraindication for cautery)
- Stop herbal supplements (ginkgo, garlic) that thin blood—ask your physician first
Test Results
Results and Interpretations
Finding / Observation | Description | General Interpretation / Significance |
---|---|---|
Benign fibroadenoma | Tight clusters of uniform cells | Routine follow-up in 6–12 months |
DCIS | Cancer cells inside duct, no invasion | Discuss lumpectomy + radiation |
IDC | Invasive cells beyond ducts | Staging and treatment plan needed |
Atypical ductal hyperplasia | Pre-cancerous changes | Surgical excision recommended |
Insufficient sample | <5 cores or extensive necrosis | Repeat biopsy or consider VAB |
Risks & Limitations
Minimal Risks
- Small bruise or hematoma (1–2 %)
- Skin infection (<0.5 %)
- Rare false-negative result (2–3 %)
Limitations
- Cannot access deep calcifications that don’t cast an ultrasound shadow
- Success depends on radiologist skill and lesion visibility
- Lesions smaller than 5 mm may be challenging to target
FAQs
How long does the procedure take?
30–45 minutes, including preparation and post-care instructions.
Is it painful?
Most women feel pressure, not pain, thanks to local anesthesia.
When can I resume normal activities?
Same day; avoid heavy lifting or strenuous exercise for 24 hours.
What if results are inconclusive?
Your physician may recommend a repeat guided breast biopsy ultrasound with VAB or proceed to surgical excision.
Does insurance cover the test?
Yes—most policies cover medically indicated breast biopsies. Our billing team will verify coverage before your appointment.